Management & Board of Directors


Lindsay A. Rosenwald, M.D.

Dr. Rosenwald has served as our Executive Chairman of the Board of Directors since inception. Dr. Rosenwald has been a member of the Board of Directors of Fortress Biotech, Inc. since October 2009 and has served as its Chairman, President and Chief Executive Officer since December 2013. Dr. Rosenwald has served as Co-Portfolio Manager and Partner of Opus Point Partners Management, LLC (“Opus Point”), an asset management firm in the life sciences industry, which he co-founded in 2009. Prior to that, from 1991 to 2008, he served as the Chairman of Paramount BioCapital, Inc. Over the last 23 years, Dr. Rosenwald has acted as a biotechnology entrepreneur and has been involved in the founding and recapitalization of numerous public and private biotechnology and life sciences companies. Dr. Rosenwald received his B.S. in finance from Pennsylvania State University and his M.D. from Temple University School of Medicine.


Hootan Khatami, M.D.

Dr. Khatami is a University of California, San Francisco (UCSF)-trained endocrinologist, with prior research in proof of concept research in leptin and HIV-associated lipoatrophy, work that contributed to orphan indication for leptin and lipoatrophy. He has been CEO and founder of Escala Therapeutics, Inc. since its inception in 2015. His career includes positions of growing responsibility in early and late-stage clinical development and medical affairs for a range of metabolic products, including global leadership for the launch of mipomersen (KynamroTM) at Genzyme/Sanofi. Prior experience also included contributing to the development of sitagliptin (JanviaTM) at Merck & Co; launch and pre-launch planning at Roche/Genentech for Taspoglutide; global medical affairs leadership for biologics & biosimilars at Sanofi; and early development and licensing/partnering at Daiichi Sankyo. Dr. Khatami received his bachelors in French and Biology at the University of California, Berkeley; M.D. degree from Albany Medical College; and training in internal medicine residency at California Pacific Medical Center, followed by an Endocrinology fellowship at UCSF.

Escala Therapeutics